Anti-Helicobacter pylori therapy in primary MALT lymphoma of rectum

Tumori

Volumn 98, Issue 4, 2012, Pages

  De Sanctis, Vitaliana ^a   Marignani, Massimo ^a   Angeletti, Stefano ^a   Assisi, Daniela ^b   Armosini, Veronica ^a   Valeriani, Maurizio ^a   Minniti, Giuseppe ^a   Cox, Maria Christina ^a   Ruco, Luigi ^a   Enrici, Riccardo Maurizi ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Endoscopic ultrasound; Helicobacter pylori; MALT; Primary rectal lymphoma

Indexed keywords

AMOXICILLIN; CD20 ANTIGEN; CLARITHROMYCIN; LANSOPRAZOLE; PROTEIN BCL 2;

AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CASE REPORT; DISEASE FREE SURVIVAL; ENDOSCOPIC ECHOGRAPHY; ERADICATION THERAPY; FOLLOW UP; GENE REARRANGEMENT; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOID HYPERPLASIA; MALE; MARGINAL ZONE LYMPHOMA; PRIMARY RECTAL MARGINAL ZONE LYMPHOMA; STOMACH BIOPSY; TREATMENT DURATION; UREA BREATH TEST;

EID: 84867225064     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/030089161209800423     Document Type: Article

References (38)

1. Isaacson P, Wright DH: Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer, 8: 15-52, 1983.
2. Ferreri AJM, Zucca E: Marginal-zone lymphoma. Crit Rev Oncol Hematol, 63: 245-256, 2007. (Pubitemid 47126862)
3. Kojima M, Itoh H, Motegi A, Sakata N, Masawa N: Localized lymphoid hyperplasia of the rectum resembling polypoid mucosa-associated lymphoid tissue lymphoma: a report of three cases. Pathol Res Pract, 201: 757-761, 2005. (Pubitemid 41679112)
4. Arcaini L, Burcheri S, Rossi A, Passamonti F, Paulli M, Boveri E, Brusamolino E, Orlandi E, Molteni A, Pulsoni A, Cox MC, Orsucci L, Fabbri A, Frezzato A, Voso MT, Zaja F, Montanari F, Pascutto C, Morra E, Cortellazzo S Lazzarino M: Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination. Oncologist, 11: 285-291, 2006.
5. Perry C, Herishanu Y, Metzer U, Bairey O, Ruchlemer R, Trejo L, Naparstek E, Sapir EE, Polliack A: Diagnostic accuracy of PET/CT in patients with extranodal marginal MALT lymphoma. Eur J Haematol, 79: 205-209, 2007. (Pubitemid 47231161)
6. Li B, Shi YK, He XH, Zou SM, Zhou SY, Dong M, Yang JL, Liu P, Xue LY: Primary non-Hodgkin lymphomas in the small and large intestine: clinicopathological characteristics and management of 40 patients. Int J Hematol, 87: 375-381, 2008.
7. Janssen J: The impact of EUS in primary gastric lymphoma. Best Pract Res Clin Gastroenterol, 23: 671-678, 2009.
8. Rahme T, Roseau G, Palazzo L: Primary rectal lymphoma: value of rectal endosonography. Ann Gastroenterol Hepatol (Paris), 25: 221-224, 1989. (Pubitemid 19253714)
9. Zrihen E, Aziza G, Crespon B: Rectal lymphoma: endorectal ultrasound aspect. Gastroenterol Clin Biol, 16: 375, 1992.
10. Gavioli M, Bagni A, Santacroce G, Piccagli I, Natalini G: Endorectal sonography appearances of rectal MALT lymphoma, its response to therapy and local recurrence. J Clin Ultrasound, 29: 401-405, 2001. (Pubitemid 32769027)
11. Maluf-Filho F, Dotti CM, Halwan B, Queiros AF, Kupski C, Chaves DM, Nakao FS, Kumar A: An evidence-based consensus statement on the role and application of endosonography in clinical practice. Endoscopy, 41: 979-987, 2009.
12. Ahlawat S, Kanber Y, Charabaty-Pishvaian A, Ozdemirli M, Cohen P, Benjamin S, Haddad N: Primary mucosa-associated lymphoid tissue (MALT) lymphoma occurring in the rectum: a case report and review of the literature. South Med J, 99: 1378-1384, 2006. (Pubitemid 46035557)
13. Ersoz F, Toros AB, Bektas H, Ozcan O, Koc O, Arikan S: MALT lymphoma of the rectum, presenting with rectal prolapsus: a case report. Cases J, 3: 33, 2010.
14. Chihara D, Kagami Y, Oki Y, Kato H, Onoda H, Ine S, Taji H, Yamamoto K, Morishima Y: R-CHOP therapy for MALT lymphoma of the rectum. Eur J Haematol, 84: 84-86, 2010.
15. Foo M, Chao MW, Gibbs P, Guiney M, Jacobs R: Successful treatment of mucosa-associated lymphoid tissue lymphoma of the rectum with radiation therapy: report of a case. Dis Colon Rectum, 51: 1719-1723, 2008.
16. Amouri A, Chtourou L, Mnif L, Mdhaffar M, Abid M, Ayedi L, Daoud J, Elloumi M, Boudawara T, Tahri N: MALT lymphoma of the rectum: a case report treated by radiotherapy. Cancer Radiother, 13: 61-64, 2009.
17. Yamamoto T, Shinji A, Ohta H, Komatsu K, Komatsu M, Yamamura N, Nakamura T: A case of rectal mucosa-associated lymphoid tissue lymphoma (MALT) successfully treated by radiation therapy. Nihon Shokakibyo Gakkai Zasshi, 108: 1231-1236, 2011.
18. Grunberger B, Wohrer S, Streubel B, Formanek M, Petkov V, Puespoek A, Haefner M, Hejna M, Jaeger U, Chott A, Raderer M: Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphoma. J Clin Oncol, 24: 1370-1375, 2006. (Pubitemid 46622000)
19. Niino D, Yamamoto K, Tsuruta O, Maeda T, Yakushijin Y, Aoki R, Kimura Y, Hashikawa K, Kiyasu J, Takeuchi M, Sugita Y, Ohshima K: Regression of rectal mucosa-associated lymphoid tissue (MALT) lymphoma after antibiotic treatments. Pathol Int, 60: 438-442, 2010.
20. Kagawa M, Okamura S, Okamoto K, Kitamura S, Kimura T, Niki M, Okahisa T, Yano M, Kagawa S, Kudo E, Sano T, Imoto Y, Wada S, Takayama T: Successful rituximab monotherapy in a patient with mucosa-associated lymphoid tissue lymphoma of the rectum with trisomy 3,18. Nihon Shokakibyo Gakkai Zasshi, 107: 612-619, 2010.
21. Asenjo LM, Gisbert JP: Prevalence of Helicobacter pylori infection in gastric MALT lymphoma: a systematic review. Rev Esp Enferm Dig, 99: 398-404, 2007.
22. Nakase H, Ohana M, Ikeda K, Uchida K, Uose S, Itoh T, Iwano M, Watanabe N, Yazumi S, Kawanami C, Inoue F, Chiba T: The possible involvement of microorganisms other than Helicobacter pylori in the development of rectal MALT lymphoma in H. pylori-negative patients. Endoscopy, 34: 343-346, 2002. (Pubitemid 34279528)
23. Dohden K, Kaizaki Y, Hosokawa O, Hayashi H, Hattori M: Regression of rectal mucosa-associated lymphoid tissue lymphoma but persistence of Helicobacter pylori infection of gastric mucosa after administration of levofloxacin: report of a case. Dis Colon Rectum, 47: 1544-1546, 2004. (Pubitemid 39295886)
24. Nomura E, Uchini K, Abue M, Kon H, Noguchi T, Suzuki S, Suzuki M, Onodera H, Tateno H, Ota Y: Regression of MALT lymphoma of the rectum after Helicobacter pylori eradication therapy in a patient negative for Helicobacter pylori. Nihon Shokakibyo Gakkai Zasshi, 107: 1466-1473, 2010.
25. Ferreri AJ: Activity of clarithromycin in mucosa-associated lymphoid tissue-type lymphomas: antiproliferative drug or simple antibiotic? Chest, 139: 724-725, 2011.
26. Aoki D, Ueno S, Kubo F, Oyama T, Sakuta T, Matsushita K, Maruyama I, Aikou T: Roxithromycin inhibits angiogenesis of human hepatoma cells in vivo by suppressing VEGF production. Anticancer Res, 25: 133-138, 2005. (Pubitemid 40470102)
27. Kurdowska A, Noble JM, Griffith DE: The effect of azithromycin and clarithromycin on ex vivo interleukin-8 (IL8) release from whole blood and IL8 production by human alveolar macrophages. J Antimicrob Chemother, 47: 867-870, 2001. (Pubitemid 32519836)
28. Ohara T, Morishita T, Suzuki H, Masaoka T, Ishii H, Hibi T: Antibiotics directly induces apoptosis in B cell lymphoma cells derived from BALB/c mice. Anticancer Res, 24: 3723-3730, 2004. (Pubitemid 40476069)
29. Hamada K, Mikasa K, Yunou Y, Kurioka T, Majima T, Narita N, Kita E: Adjuvant effect of clarithromycin on chemotehrapy for murine lung cancer. Chemotherapy, 46: 49-61, 2000. (Pubitemid 30009334)
30. Niesvizky R, Jayabalan DS, Christos PJ, Furst JR, Naib T, Ely S, Jalbrzikowski J, Pearse RN, Zafar F, Pekle K, Larow A, Lent R, Mark T, Cho HJ, Shore T, Tepler J, Harpel J, Schuster MW, Mathew S, Leonard JP, Mazumdar M, Chen-Kiang S, Coleman M: BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexametasone) combination therapy results in high complete and overall response rates in treatment-naive symptomatic multiple myeloma. Blood, 111: 1101-1109, 2008. (Pubitemid 351213388)
31. Sauter C, Blum S: Regression of lung lesions in Hodgkin's disease by antibiotics: case report and hypothesis on the etiology of Hodgkin disease. Am J Clin Oncol, 26: 92-94, 2003. (Pubitemid 36205904)
32. Arima N, Tsudo M: Extragastric mucosa-associated lymphoid tissue lymphoma showing the regression by Helicobacter pylori eradication therapy. Br J Hematol, 120: 790-792, 2003. (Pubitemid 36315100)
33. Govi S, Dognini GP, Licata G, Crocchialo R, Resti AG, Ponzoni M, Ferreri AJM: Six-month oral clarithromycin regimen is safe and active in extranodal marginal zone B-cell lymphomas: final results of a single-centre phase II trial. Br J Haematol, 150: 226-229, 2010.
34. Wang L, Kitaichi K, Hui CS, Takagi K, Takagi K, Sakai M, Yokogawa K, Miyamoto KI, Hasegawa T: Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo. Clin Exp Pharmacol Physiol, 27: 587-593, 2000. (Pubitemid 30436195)
35. Takenaka R, Tomoda J, Sakata T, Ichiba T, Motoi M, Mizuno M, Tsuji T: Mucosa-associated lymphoid tissue lymphoma of the rectum that regressed spontaneously. J Gastroenterol Hepatol, 15: 331-335, 2000. (Pubitemid 30190752)
36. Okamura S, Katsuhiko H, Satoh T: Regression of rectal mucosa-associated lymphoid tissue lymphoma unrelated to helicobacter pylori. Ann Intern Med, 132: 247, 2000. (Pubitemid 30064931)
37. Nakamura T, Nakamura S, Yokoi T, Suzuki H, Ohashi K, Seto M: Clinicopathologic comparison between the AP12-MALT1 chimeric transcript-positive and -negative gastric low grade B cell lymphoma of mucosa-associated lymphoid tissue type. Jpn J Cancer Res, 93: 677-684, 2002. (Pubitemid 34846275)
38. Sakugawa ST, Yoshino T, Nakamura S: AP12-MALT1 fusion gene in colorectal lymphoma. Mod Pathol, 16: 1234-1241, 2003.